C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
11/2004
11/23/2004	US6821998 Arylamines as inhibitors of chemokine binding to US28
11/23/2004	US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/23/2004	US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases
11/23/2004	CA2330942C Piperazine derivatives and process for the preparation thereof
11/18/2004	WO2004099161A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
11/18/2004	WO2004098602A1 Melanocortin receptor-specific compounds
11/18/2004	US20040229955 Antibacterial agents
11/18/2004	US20040229884 Sodium channel blockers
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229819 Hemiasterlin derivatives and uses thereof
11/18/2004	CA2525195A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
11/17/2004	EP1477482A1 Novel phenylalanine derivative
11/17/2004	EP1476753A2 Functionalized compositions for improved immobilization
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1289999B1 Antitumoral analogs of et-743
11/17/2004	EP1087953B1 Nitrate salts of antihypertensive medicines
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	CN1546474A Method for preparing tetramethyl pyrazine
11/16/2004	US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004	US6818637 For use as antidiabetic agent
11/11/2004	WO2004096780A1 Quinoxalinone-3- one derivatives as orexin receptor antagonists
11/11/2004	WO2004096771A1 Biaryl compounds having activity at the 5ht5a receptor
11/11/2004	WO2004067675A3 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040224985 for controlling weight; pyrrolidine or piperidine compounds
11/11/2004	US20040224957 Melanocortin receptor-specific compounds
11/11/2004	US20040224954 Substituted 1H-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
11/11/2004	CA2520839A1 Quinoxalinone-3- one derivatives as orexin receptor antagonists
11/10/2004	EP1474401A2 Novel aryl- and heteroarylpiperazines
11/10/2004	EP0859764B1 PROCESS FOR THE CONTINUOUS PRODUCTION OF BASIC CYCLIC OPTICALLY ACTIVE alpha-AMINO ACIDS
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/09/2004	US6815442 Quinoxalinones for enhancing chemotherapy
11/04/2004	WO2004094389A1 Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives
11/04/2004	WO2004094384A2 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2004056774A3 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
11/04/2004	WO2004037797A3 2 - alkyl - (2 - amino - 3 - aryl - propionyl) - piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity
11/04/2004	US20040220403 For therapy and prophylaxis of Tachykinin-mediated diseases
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220112 administering 2-(N-Methylsulfonamido-2-aminophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide as an anti-pruritic agent; antihyperalgesics; analgesics; central nervous system side effect reduction
11/04/2004	CA2523232A1 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer's disease
11/03/2004	EP1473289A1 Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
11/03/2004	EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004	EP1305278B1 Ruthenium complexes and their use in asymmetric hydrogenation
11/03/2004	CN1543461A Melanocortin receptor ligands
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
11/03/2004	CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004	CN1173958C Compound capable of inhibiting thrombocyte agglutination and resisting thrombosis and its preparation and application
11/03/2004	CN1173957C Substituted piperazones and their therapeutic use
11/03/2004	CN1173946C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/02/2004	CA2129040C Styryl derivatives and processes for their preparation
10/2004
10/28/2004	WO2004092135A2 Substituted benzosulphonamide as potentiators of glutamate receptors
10/28/2004	WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004	WO2004076386A3 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
10/28/2004	WO2003018515A3 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214832 Piperazine derivative renin inhibitors
10/28/2004	US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
10/28/2004	CA2527170A1 Therapeutic compounds
10/27/2004	EP1470752A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives
10/27/2004	EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/27/2004	EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
10/27/2004	CN1539833A Funcitonal molecule material containing four tertiary amine branches and preparation method
10/27/2004	CN1539828A Nitrogen-contg. heterocyclic carboxamide derivatives or salt thereof
10/27/2004	CN1172920C Process for producing 2-(4-alkyl-1-piperazyl)-benzaldehyde and-benzal compound
10/26/2004	US6809202 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
10/26/2004	US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection
10/26/2004	US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
10/26/2004	US6809088 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
10/26/2004	US6808884 Intercalation compound for use in the diagnosis and detection of genetic disorders
10/21/2004	WO2004089915A1 Piperazine derivative renin inhibitors
10/21/2004	US20040209893 treatment of a condition mediated by a tachykinin including substance P and other neurokinins by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic Acid (3,5-bistrifuoromethyl-benzyl)-methyl-amide Hydrochloride .
10/21/2004	US20040209890 Polyhydroxyalkylpyrazine derivatives, their preparation and medicaments comprising them
10/21/2004	US20040209865 use for reducing body weight and treating urinary incontinence; Melanin-concentrating hormone (MCH); 5-(4-chloro-phenyl)-2-[5-(2-pyrrolidin-1-yl-ethoxy)-pyridin-2-yl-ethynyl]-pyridine for example
10/21/2004	US20040209846 Heterocyclic analgesic compounds and methods of use thereof
10/21/2004	CA2521400A1 Piperazine derivative renin inhibitors
10/20/2004	EP1468994A1 Process for preparing cyclic amine substituted phenyl-alkyl-ketones
10/20/2004	EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
10/20/2004	EP1467723A1 Phenyl sulfoxides and phenyl sulfones
10/20/2004	EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/14/2004	WO2004056727A3 Process of making chalcone derivatives
10/14/2004	WO2004000762A3 Propionic acid derivatives and their use as hppars activators
10/14/2004	US20040204450 For therapy of atherosclerosis, coronary artery disease, coronary heart disease, coronary vascular disease, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemia, familial-hypercholesterolemia
10/14/2004	US20040204425 Sodium channel blockers
10/14/2004	US20040204424 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders
10/14/2004	US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders
10/13/2004	EP1466899A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
10/13/2004	EP1466605A2 Calcium channel blockers
10/13/2004	EP1465854A2 Chalcone derivatives and their use to treat diseases
10/13/2004	EP1465586A1 Cosmetic compositions comprising a cyclodipeptide compound
10/13/2004	EP1465585A1 Cosmetic compositions comprising a cyclodipeptide compound
10/13/2004	EP1465488A1 Arylamines as inhibitors of chemokine binding to us28
10/13/2004	EP1280797B1 Inhibitors of dipeptidyl peptidase iv
10/13/2004	CN1537102A Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
10/13/2004	CN1537016A Remedies for psychoneurosis
10/13/2004	CN1170826C Amide compounds
10/13/2004	CN1170813C N2 phenylamidine derivatives and fungicidal composition and use
10/12/2004	US6803464 Reacting acid salt of aminoacetamidine with a source-of cyanide and reacting with 2,3,5-trichlorobenzaldehyde to produce 2-((cyano-(2,3,5-trichlorophenyl)-methyl)-amino)-acetamidine or a salt thereof

1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 187